Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00987415 · ClinicalTrials.gov registry record · Phase 2
Using Allopurinol to Relieve Symptoms in Patients With Heart Failure and High Uric Acid Levels
A Phase 2 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 2
- Development phase
- 253
- Enrollment target
NCT00987415: Completed Phase 2 study, sponsored by Duke University.
NCT00987415 is a Phase 2 study that has completed, run by Duke University. The registered enrollment target is 253 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (90% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00987415, a Phase 2 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 253 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether allopurinol is effective in relieving symptoms of patients with heart failure and high blood uric acid levels.
Primary Outcome
CCE composed of 3-level categorical variable with options that include worsened, unchanged or improved
Interventions
- DRUG allopurinol
- DRUG sugar pill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 253 participants |
| Start Date | 2010-05 |
| Est. Completion | 2014-06 |
| Phase | Phase 2 |
What the finished NCT00987415 record still lists
NCT00987415 is an interventional study that assigns participants to a tested intervention. The registered 253 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (90% higher).
The record links to 0 conditions, and to 2 interventions - of which allopurinol is the first listed.
NCT00987415 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00987415 about?
NCT00987415 is a clinical study titled "Using Allopurinol to Relieve Symptoms in Patients With Heart Failure and High Uric Acid Levels". The purpose of this study is to determine whether allopurinol is effective in relieving symptoms of patients with heart failure and high blood uric acid levels.
What is the current status of trial NCT00987415?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 253 participants. The study started on 2010-05. Estimated completion is 2014-06.
What interventions are being tested in trial NCT00987415?
The interventions under investigation include: allopurinol (DRUG), sugar pill (DRUG).
Who is sponsoring clinical trial NCT00987415?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00987415's enrollment target sits among peer trials
253 220th of 2000 higher than 1,781 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04390737 · 254 participants · Phase 1
Evaluate the Safety and Clinical Activity of HH2853
- NCT04677647 · 254 participants · NA
OurChild: A Health IT Solution to Reduce Minority Health Disparities
- NCT05503797 · 254 participants · Phase 2
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- NCT06167317 · 254 participants · Phase 1
Study of GS-0201 Alone and in Combination in Participants With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia